RSG
Member
- Reaction score
- 0
Guys take a look at this article, interesting read.
However interesting to note that the pathologist here recieved "grants/research support from GlaxoSmithKline". My question is, why would he be receiving grants from Glaxo and not Merck? Could be it possible that Glaxo want to debunke this fanasteride link with high-grade prostate cancer because they are pushing for FDA approval for thier own product? dutasteride? maybe a new dht blocker?
Commets?
http://www.urologytimes.com/urologytime ... ?id=317927
However interesting to note that the pathologist here recieved "grants/research support from GlaxoSmithKline". My question is, why would he be receiving grants from Glaxo and not Merck? Could be it possible that Glaxo want to debunke this fanasteride link with high-grade prostate cancer because they are pushing for FDA approval for thier own product? dutasteride? maybe a new dht blocker?
Commets?
http://www.urologytimes.com/urologytime ... ?id=317927